IL17A and adenoma: Significant enrichments of immune or inflammatory pathways such as B-cell differentiation, rheumatoid arthritis, and interleukin (IL)-17 pathways in Fig. 2c,d may suggest the importance of immunological landscapes in the adenoma-carcinoma sequence.